The Combined Use of Gene Expression Profile and Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients: The Mid America Experience

A. Kao, J. Linard, B.A. Austin, M.P. Everley,T.J. Fendler,T.M. Khumri,S.L. Lawhorn,A. Magalski,M.E. Nassif,B.W. Sperry,D. Vodnala,A.M. Borkon

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览9

暂无评分

摘要

Adding dd-cfDNA to GEP testing helped reclassify some GEP positive only pts into a lower risk group with an additional 11% of EMBs cancelled. Further evaluation of the utility of the combined use of GEP and dd-cfDNA is warranted.

查看译文

关键词

heart transplant patients,gene expression profile,gene expression,donor-derived,cell-free

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要